While considered a relatively novel term in research, biomarkers and diagnostics have been extensively used in the pre-clinical and clinical research and diagnosis arena for many years. Their magnitude in positively influencing the medical community’s ability to accurately diagnose and treat human conditions, although still undefined, seems limitless. Currently, a renewed focus is being placed on healthcare outcomes, and the containment of medical cost, diagnostics, biomarkers and personalized medicine are fostering better outcomes and savings.
In this Webinar, our speakers discuss how the need for more clinical applications for diagnostic biomarker testing is expected to have an explosive growth among several disease categories in the five years. They also explain how the operational execution of biomarker and diagnostic research varies greatly from traditional clinical research, while looking at the unique requirements and challenges.
Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting is being presented by Dr. Jerome Wilson & Kathleen Kushner, Sr. Scientific Affairs Director & Scientific Affairs Director, Late Phase Services, with PRA International and airs on Tuesday, February 23, 2010. For more details or to register for this event, please visit our site at www.fxconferences.com
